This nested case-control study explores the association of impaired CYP2D6 genotype and metabolic phenotype activity with failure of high-dose primaquine treatment for Plasmodium vivax malaria relapse in Indonesian men. Here, CYP2D6 is linked to Plasmodium vivax malaria.